Old Web
English
Sign In
Acemap
>
authorDetail
>
Paul F. Miller
Paul F. Miller
Pfizer
Pharmacology
Mycobacterium tuberculosis
Pharmacokinetics
Medicine
Biology
6
Papers
340
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Linezolid, the first oxazolidinone antibacterial agent
2011
Annals of the New York Academy of Sciences
Karen L. Leach
Steven J. Brickner
Mark C. Noe
Paul F. Miller
Show All
Source
Cite
Save
Citations (107)
Biomarker-assisted dose selection for safety and efficacy in early development of PNU-100480 for tuberculosis.
2011
Antimicrobial Agents and Chemotherapy
Robert S. Wallis
Wesley Jakubiec
Vikas Kumar
Gabriella Bedarida
Annette M. Silvia
Darcy Paige
Tong Zhu
Mark J. Mitton-Fry
Lynn Ladutko
Sheldon Campbell
Paul F. Miller
Show All
Source
Cite
Save
Citations (97)
Pharmacokinetics and Whole-Blood Bactericidal Activity against Mycobacterium tuberculosis of Single Doses of PNU-100480 in Healthy Volunteers
2010
The Journal of Infectious Diseases
Robert S. Wallis
Wesley Jakubiec
Vikas Kumar
Annette M. Silvia
Darcy Paige
Dessislava Dimitrova
Xiaoxi Li
Lynn Ladutko
Sheldon Campbell
Gerald Friedland
Mark J. Mitton-Fry
Paul F. Miller
Show All
Source
Cite
Save
Citations (77)
Key pathogens and emerging therapies in infectious diseases.
2009
Current Opinion in Pharmacology
Paul F. Miller
John P. Mueller
Show All
Source
Cite
Save
Citations (0)
1